Skip to main content
Top
Published in: Acta Diabetologica 2/2013

01-04-2013 | Original Article

The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea

Authors: Mi-Oh Roh, Chan-Hee Jung, Bo-Yeon Kim, Ji-Oh Mok, Chul-Hee Kim

Published in: Acta Diabetologica | Issue 2/2013

Login to get access

Abstract

Few studies were performed to evaluate the prevalence of latent autoimmune diabetes in adults (LADA) and the difference of chronic complications between LADA, T1DM, and T2DM in Korean. The aim of this study is to establish the prevalence of LADA in a diabetic clinic of Soonchunhyang University hospital and to compare the phenotypic characteristics according to DM classification based on positivity of glutamic acid decarboxylase antibodies (GADA). Also, another important point concerns the occurrence of diabetes chronic microvascular complications in LADA. 323 patients who were checked GADA among diabetic patients admitted at Soonchunhyang University hospital were recruited. Twenty-eight patients (8.7%) were identified as positive for GADA. 11.5% (n = 37) were diagnosed with T1DM and 5.3% (n = 17) were diagnosed with LADA. GADA titer showed significant negative correlation with age of onset, total cholesterol (TC), triglyceride (TG), fasting C-peptide, stimulated C-peptide, BMI, and positive correlation with HbA1C and HDL-C. Compared with those that tested negative for GADA, patients with GADA positive had lower values of onset age, BMI, TC, TG, LDL-C, fasting, and stimulated C-peptide levels and higher values of HbA1C. A significant gradual increase of values was observed for the onset age, BMI, SBP, DBP, fasting, and stimulated C-peptide across the T1DM, LADA, and T2DM subgroups. Concerning the chronic complications there was no difference in prevalence of retinopathy, neuropathy and nephropathy between three groups. Of LADA patients, 12 patients were receiving insulin treatment and mean time to insulin initiation was about 37 months. In conclusion, because our study suggests LADA subgroups in Korea appear to have a faster decline in C-peptide levels, it is worth detecting the patients with LADA early and effort to preserve beta cell function. Furthermore, our results showed that the prevalence of microvascular complication was comparable between the subgroups.
Literature
1.
go back to reference Groop LC, Bottazo GF, Doniach D (1986) Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes 35:237–241PubMedCrossRef Groop LC, Bottazo GF, Doniach D (1986) Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes 35:237–241PubMedCrossRef
2.
go back to reference Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent autoimmune diabetes in adults: definition, prevalence, β-cell function, and treatment. Diabetes 54:S68–S72PubMedCrossRef Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent autoimmune diabetes in adults: definition, prevalence, β-cell function, and treatment. Diabetes 54:S68–S72PubMedCrossRef
3.
go back to reference Turner R, Statton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in Type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288–1293PubMedCrossRef Turner R, Statton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in Type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288–1293PubMedCrossRef
4.
go back to reference Zimmet PZ (1995) The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 18:1025–1064 Zimmet PZ (1995) The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 18:1025–1064
5.
go back to reference Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157PubMedCrossRef Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157PubMedCrossRef
6.
go back to reference Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G (2004) A clinically oriented approach increases the efficacy of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med 21:456–459PubMedCrossRef Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G (2004) A clinically oriented approach increases the efficacy of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med 21:456–459PubMedCrossRef
7.
go back to reference Ruige JB, Batstra MR, Aanstoot HJ, Bouter LM, Bruining GJ, de Neeling JND, Heine RJ (1997) Low prevalence of antibodies to GAD 65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care 20:1108–1110PubMedCrossRef Ruige JB, Batstra MR, Aanstoot HJ, Bouter LM, Bruining GJ, de Neeling JND, Heine RJ (1997) Low prevalence of antibodies to GAD 65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care 20:1108–1110PubMedCrossRef
8.
go back to reference Bosi EP, Garancini MP, Poggiali F, Bonifacio E, Gallus G (1999) Low prevalence of islet autoimmunity in adult diabetes and low predictive value of autoantibodies in the general adult population of northern Italy. Diabetologia 42:840–844PubMedCrossRef Bosi EP, Garancini MP, Poggiali F, Bonifacio E, Gallus G (1999) Low prevalence of islet autoimmunity in adult diabetes and low predictive value of autoantibodies in the general adult population of northern Italy. Diabetologia 42:840–844PubMedCrossRef
9.
go back to reference Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368:1681–1688PubMedCrossRef Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368:1681–1688PubMedCrossRef
10.
go back to reference Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, Baik SH, Choi DS, Choi KM (2006) Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey. Diabetes Care 29:226–231PubMedCrossRef Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, Baik SH, Choi DS, Choi KM (2006) Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey. Diabetes Care 29:226–231PubMedCrossRef
11.
go back to reference Torn C (2003) C-peptide and autoimmune markers in diabetes. Clin Lab 49:1–10PubMed Torn C (2003) C-peptide and autoimmune markers in diabetes. Clin Lab 49:1–10PubMed
12.
go back to reference Borg H, Gottsater A, Fernlund P, Sundkvist G (2002) A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754–1762PubMedCrossRef Borg H, Gottsater A, Fernlund P, Sundkvist G (2002) A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754–1762PubMedCrossRef
13.
go back to reference Arikan E, Sabuncu T, Ozer EM, Hatemi H (2005) The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. J Diabetes Complications 19:254–258PubMedCrossRef Arikan E, Sabuncu T, Ozer EM, Hatemi H (2005) The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. J Diabetes Complications 19:254–258PubMedCrossRef
14.
go back to reference Zinman B, Kahn SE, Haffner SM, O’Neill MC, Heise MA, Feed MI (2004) Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with Type 2 diabetes in North America and Europe. Diabetes 53:3193–3200PubMedCrossRef Zinman B, Kahn SE, Haffner SM, O’Neill MC, Heise MA, Feed MI (2004) Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with Type 2 diabetes in North America and Europe. Diabetes 53:3193–3200PubMedCrossRef
15.
go back to reference Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J (2001) Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005–1010PubMedCrossRef Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J (2001) Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005–1010PubMedCrossRef
16.
go back to reference Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 17:667–674PubMedCrossRef Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 17:667–674PubMedCrossRef
17.
go back to reference Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TME (2008) Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med 25:1245–1250PubMedCrossRef Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TME (2008) Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med 25:1245–1250PubMedCrossRef
18.
go back to reference Balme M, McAllister I, Davis WA, Davis TM (2002) Retinopathy in latent autoimmune diabetes of adults: the Fremantle Diabetes Study. Diabet Med 19:602–605PubMedCrossRef Balme M, McAllister I, Davis WA, Davis TM (2002) Retinopathy in latent autoimmune diabetes of adults: the Fremantle Diabetes Study. Diabet Med 19:602–605PubMedCrossRef
19.
go back to reference Isomaa B, Almgren P, Henricsson M, Taskinen MR, Tuomi T, Groop L, Sarelin L (1999) Chronic complications in patients with slowly progressing autoimmune Type 1 diabetes (LADA). Diabetes Care 22:1347–1353PubMedCrossRef Isomaa B, Almgren P, Henricsson M, Taskinen MR, Tuomi T, Groop L, Sarelin L (1999) Chronic complications in patients with slowly progressing autoimmune Type 1 diabetes (LADA). Diabetes Care 22:1347–1353PubMedCrossRef
20.
go back to reference Schiel R, Muller UA (2000) GAD autoantibodies in a selection-free population of insulin-treated diabetic patients: indicator of a high prevalence of LADA? Diabetes Res Clin Pract 49:33–40PubMedCrossRef Schiel R, Muller UA (2000) GAD autoantibodies in a selection-free population of insulin-treated diabetic patients: indicator of a high prevalence of LADA? Diabetes Res Clin Pract 49:33–40PubMedCrossRef
21.
go back to reference Kim CS, Park JA, Cho MH, Park JS, Nam JY, Kim DM, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC (2004) The frequency of Anti-GAD antibody in non-obese, adult-onset type 2 diabetes in Korea and clinical and biological characteristics according to anti-GAD antibody. J Korean Diabetes Assoc 28:66–74 Kim CS, Park JA, Cho MH, Park JS, Nam JY, Kim DM, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC (2004) The frequency of Anti-GAD antibody in non-obese, adult-onset type 2 diabetes in Korea and clinical and biological characteristics according to anti-GAD antibody. J Korean Diabetes Assoc 28:66–74
22.
go back to reference Park YS (2004) The significance of anti-GAD antibodies in lean patients with type 2 diabetes mellitus. Korean Diabetes J 28:63–65 Park YS (2004) The significance of anti-GAD antibodies in lean patients with type 2 diabetes mellitus. Korean Diabetes J 28:63–65
23.
go back to reference Park Y, Lee H, Koh CS, Min H, Rowley M, Mackay IR, Zimmet P, McCarthy B, McCanlies E, Dorman J, Trucco M (1996) The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 19:241–245PubMedCrossRef Park Y, Lee H, Koh CS, Min H, Rowley M, Mackay IR, Zimmet P, McCarthy B, McCanlies E, Dorman J, Trucco M (1996) The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 19:241–245PubMedCrossRef
24.
go back to reference Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y (1995) Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Clin Pract 28:191–199PubMedCrossRef Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y (1995) Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Clin Pract 28:191–199PubMedCrossRef
25.
go back to reference Inukai T, Fujiwara Y, Tayama K, Aso Y, Ogino K, Takemura Y (1997) Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. Exp Clin Endocrinol Diabetes 105:327–330PubMedCrossRef Inukai T, Fujiwara Y, Tayama K, Aso Y, Ogino K, Takemura Y (1997) Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. Exp Clin Endocrinol Diabetes 105:327–330PubMedCrossRef
26.
go back to reference Lee SA, Kim EY, Kim EH, Jeong JY, Jeong EH, Kim DW, Cho EH, Koh EH, Kim MS, Park JY, Lee KU (2009) Anti-GAD Antibody in patients with adult-onset diabetes in Korea. Korean Diabetes J 33:16–23CrossRef Lee SA, Kim EY, Kim EH, Jeong JY, Jeong EH, Kim DW, Cho EH, Koh EH, Kim MS, Park JY, Lee KU (2009) Anti-GAD Antibody in patients with adult-onset diabetes in Korea. Korean Diabetes J 33:16–23CrossRef
27.
go back to reference Lee SH, Kwon HS, Yoo SJ, Ahn YB, Yoon KU, Cha BY, Lee KW, Son HY (2009) Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome. Diabetes Res Clin Pract 83:e62–e65PubMedCrossRef Lee SH, Kwon HS, Yoo SJ, Ahn YB, Yoon KU, Cha BY, Lee KW, Son HY (2009) Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome. Diabetes Res Clin Pract 83:e62–e65PubMedCrossRef
28.
go back to reference Rosario PW, Reis JS, Amim R, Fagundes TA, Calsolari MR, Silva SC, Purisch S (2005) Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care 28:1803–1804PubMedCrossRef Rosario PW, Reis JS, Amim R, Fagundes TA, Calsolari MR, Silva SC, Purisch S (2005) Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care 28:1803–1804PubMedCrossRef
29.
go back to reference Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R, de Leiva A, Pozzilli P, Leslie PD (2009) Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care 32:160–164PubMedCrossRef Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R, de Leiva A, Pozzilli P, Leslie PD (2009) Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care 32:160–164PubMedCrossRef
30.
go back to reference Katulanda P, Shine B, Katulanda W, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR (2008) Diabetes mellitus among young adults in Sri Lanka-role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes Study. Diabetologia 51:1368–1374PubMedCrossRef Katulanda P, Shine B, Katulanda W, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR (2008) Diabetes mellitus among young adults in Sri Lanka-role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes Study. Diabetologia 51:1368–1374PubMedCrossRef
Metadata
Title
The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea
Authors
Mi-Oh Roh
Chan-Hee Jung
Bo-Yeon Kim
Ji-Oh Mok
Chul-Hee Kim
Publication date
01-04-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0228-y

Other articles of this Issue 2/2013

Acta Diabetologica 2/2013 Go to the issue